11-47342698-G-A

Variant summary

Our verdict is Pathogenic.
+12 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 12 classification points (ACMG Germline Pathogenicity v2019). PS3PM1PM5PP5_Strong

The NM_000256.3(MYBPC3):c.1504C>T (p.Arg502Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000144 (AC=233) in the gnomAD database across 1,613,896 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000167. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV004834613: "A functional study has shown that this variant causes a loss of protein function with no evidence of the transcript or protein degradation and may alter kinetics of cardiac muscle contraction and relaxation (PMID:30554920)."" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R502Q: Pathogenic (ClinVar VariationId 42541, 3 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R502= (synonymous): Likely_benign (ClinVar VariationId 629638, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

MYBPC3
NM_000256.3 missense

Scores

13
7

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:39O:2

Conservation

PhyloP100: 4.49

Publications

84 publications found
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
MYBPC3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 4
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • left ventricular noncompaction 10
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • dilated cardiomyopathy
    Inheritance: AD, AR Classification: LIMITED Submitted by: ClinGen
  • familial dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000256.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 12 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV004834613: "A functional study has shown that this variant causes a loss of protein function with no evidence of the transcript or protein degradation and may alter kinetics of cardiac muscle contraction and relaxation (PMID: 30554920)."; SCV000208031: Published functional studies using cardiomyocytes derived from induced pluripotent stem cells demonstrate R502W alters protein function (Cohn et al., 2019);; SCV000604327: Functional analyses suggest the variant protein has impaired interaction with sarcomeric binding partner proteins (Zhang 2014). PMID: 25058872.; SCV000696313: Structure study predicted the R502W mutation and other HCM-linked mutations found within the same C3 domain, may directly disrupt the interaction of cMyBP-C with other sarcomeric proteins (Zhang_2014).; SCV001357620: "A functional study has shown that this variant causes a loss of protein function with no evidence of the transcript or protein degradation, and may alter kinetics of cardiac muscle contraction and relaxation (PMID: 30554920)."
PM1Mutational hot spot or critical domain
Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 4 pathogenic, 1 benign (OR vs. background: 15.0).
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R502Q: Pathogenic (ClinVar VariationId 42541, 3 stars); Other variants at the same amino acid residue (not pathogenic): p.R502= (synonymous): Likely_benign (ClinVar VariationId 629638, 1 star)
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (39/39 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000256.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MYBPC3 NM_000256.3
MANE Select
HGVSc / HGVSpc.1504C>Tp.Arg502Trp
Exon rankExon 17 of 35
missense
Prot: NP_000247.2UniProt: Q14896-1A5YM48

Ensembl Transcripts

MYBPC3 ENST00000545968.6
TSL:5MANE Select
HGVSc / HGVSpc.1504C>Tp.Arg502Trp
Exon rankExon 17 of 35
missense
Prot: ENSP00000442795.1UniProt: Q14896-1
MYBPC3 ENST00000399249.6
TSL:5
HGVSc / HGVSpc.1504C>Tp.Arg502Trp
Exon rankExon 16 of 34
missense
Prot: ENSP00000382193.2UniProt: A8MXZ9
MYBPC3 ENST00000544791.1
TSL:5
HGVSc / HGVSpn.1504C>T
Exon rankExon 17 of 27
non_coding_transcript_exon
Prot: ENSP00000444259.1UniProt: F5GZR4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0000854
AC:13
Hom:0
AN:152198
Cov:33
GnomAD2 exomes
AF: 0.0000401
AC:10
AN:249240
GnomAD4 exome
AF: 0.000151
AC:220
Hom:0
AN:1461698
Cov:31
GnomAD4 genome
AF: 0.0000854
AC:13
Hom:0
AN:152198
Cov:33
TOPMed (Bravo)
AF: 0.0000756
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.000121
AC:28
Hom:0
AN:232282
Local & regional cohorts 3 sources
ESP6500 (Exome Variant Server)
AF: 0.0000779
AC:1
AN:12838
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0000160
AC:2
Hom:0
AN:122464
UK10K
AF: 0.000264
AC:2
AN:7562
Showing 9 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.0000352 128420 0.000208 628844
Epi25
(Epilepsy)
0.000167 741958 0.0000598 466888
SCHEMA
(Schizophrenia)
0.0000985 12121836 0.0000630 12190566
Showing 3 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
13
-
-
not provided (13)
9
-
-
Hypertrophic cardiomyopathy 4 (9)
5
-
-
Hypertrophic cardiomyopathy (6)
3
-
-
Cardiovascular phenotype (3)
3
-
-
MYBPC3-related disorder (3)
2
-
-
Cardiomyopathy (2)
1
-
-
Hypertrophic cardiomyopathy 1 (1)
1
-
-
Left ventricular noncompaction 10 (1)
1
-
-
MYBPC3-related cardiomyopathies (1)
1
-
-
Primary familial hypertrophic cardiomyopathy (1)
-
-
-
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 (1)

Computational Scores

AlphaGenome AVI
Pathogenic24
AlphaMissense
Uncertain0.40
BayesDel_addAF
Pathogenic0.26D
BayesDel_noAF
Pathogenic0.34
CADD
Pathogenic30
CardioboostCm
Pathogenic0.93
DANN
Pathogenic1.0
DEOGEN2
Pathogenic0.80D
Eigen
Uncertain0.62
Eigen_PC
Uncertain0.58
FATHMM_MKL
Uncertain0.96D
GPN-Star LLR
N/A-6.9
GPN-Star score
N/A6.6
LIST_S2
Pathogenic0.98D
M_CAP
Pathogenic0.48D
MetaRNN
Pathogenic0.90D
MetaSVM
Uncertain0.12D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Pathogenic3.5H
PhyloP100
Uncertain4.5
popEVE
Benign-3.5
PrimateAI
Uncertain0.73T
PROVEAN
Pathogenic-6.6D
REVEL
Uncertain0.64
Sift
Pathogenic0.0D
Sift4G
Pathogenic0.0D
Varity_R
N/A0.72
VESM-3B
Benign-11
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.020
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.